Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice - Wikidata - wikimedia - TriplyDB

Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice

Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice

http://www.wikidata.org/entity/Q37118772

about

Molecular docking simulations provide insights in the substrate binding sites and possible substrates of the ABCC6 transporter Role of Intestinal LXRα in Regulating Post-prandial Lipid Excursion and Diet-Induced Hypercholesterolemia and Hepatic Lipid Accumulation.Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis.Molecular Properties of Guar Gum and Pectin Modify Cecal Bile Acids, Microbiota, and Plasma Lipopolysaccharide-Binding Protein in Rats.Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists.Dissociated sterol-based liver X receptor agonists as therapeutics for chronic inflammatory diseases.Enzyme-Linked Immunosorbent Assay for Hyodeoxycholic Acid in Pharmaceutical Products Using a Monoclonal Antibody

P2860

Q28541190-237849F4-41F8-47E0-9A20-9C4C1A85BCD0 Q33650363-8E8D4668-81C1-411C-9979-EAF1C80A9B43 Q34757435-E2872A67-1569-4654-9222-1245A94A1D0F Q36055503-154AA1B4-121C-4424-9F4E-64907E5FF99D Q36289268-4BE3FF85-CEBD-4D59-87A3-96296E4C0E0A Q36996334-9DF8D0B4-3567-447E-A3F9-7E937273A08B Q58255373-EC17995E-7E5E-47F9-80A6-744DF6EF9EA9

P2860

Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice

http://www.wikidata.org/entity/Q37118772

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hyodeoxycholic acid improves H ...... ormation in LDLR-knockout mice

@en

Hyodeoxycholic acid improves H ...... rmation in LDLR-knockout mice.

@nl

type

label

Hyodeoxycholic acid improves H ...... ormation in LDLR-knockout mice

@en

Hyodeoxycholic acid improves H ...... rmation in LDLR-knockout mice.

@nl

prefLabel

Hyodeoxycholic acid improves H ...... ormation in LDLR-knockout mice

@en

Hyodeoxycholic acid improves H ...... rmation in LDLR-knockout mice.

@nl

P1433

Q37118772-76B21822-8F33-4B2B-8FB7-B6B7DF4E5DE6

P1476

Q37118772-1897DCAB-77E7-4399-A648-1E0021A4B037

P2093

Q37118772-006F38D7-A529-4ED8-A157-B72A529C5DD6

Q37118772-1DEAA103-ADCE-4CF4-813C-C7614A067288

Q37118772-270F13B6-5A69-4B15-A6B4-20637C3F7FC1

Q37118772-325FFA4D-D137-4B6F-A8AD-FF6233799273

Q37118772-3ED042E4-BDA5-4039-BF8F-F16B9936FDA7

Q37118772-8DF37E64-08BC-4B5F-9B08-C5B10C941757

Q37118772-C8BF9C93-CD5F-41DE-AFA4-14E25BBB5696

Q37118772-CFAB8342-C08C-42EC-9309-58F724702719

Q37118772-FA1EAAED-CDB2-42AB-A9BD-4EAFDB55A496

P2860

Q37118772-06EEFAE6-1C5C-46C1-ACD5-CD427172F353

Q37118772-10D40260-3B14-43F4-BBFD-8E208E0B9EAA

Q37118772-1178BBA9-6AA9-4526-938B-7C618C49876D

Q37118772-11DC7419-DD77-4111-B766-15A902960590

Q37118772-23CDBB59-57E5-49B4-B73B-B105776A3ADC

Q37118772-29A64BB1-A570-4FD9-9DD4-489152E87D32

Q37118772-35DB650A-CAE5-48FA-8663-22FE8118950B

Q37118772-368735D7-6160-42F4-8663-C26769876851

Q37118772-3790549E-4E6B-4AAA-84B9-FA309F5B2B26

Q37118772-3A98A0DF-B9BD-41FF-81F2-26A56E53A227

P304

Q37118772-3C1A0B8D-123B-4DF5-A825-042AD816D71B

P31

Q37118772-A811379F-E301-4C71-91C6-A59B733CF537

P356

Q37118772-2C86FC87-02D1-48F7-9AFA-731069BA5902

P407

Q37118772-3CD4A9FB-3063-483F-9A8E-65344EB1CFD0

P433

Q37118772-AC89D9FB-5718-4103-AF70-E3F711238C7B

P478

Q37118772-6093ED4F-E37F-4566-9DEA-99CA20DD55D1

P50

Q37118772-ECA7D582-247E-445B-975D-AE47DBD5D559

P577

Q37118772-2CC066F6-4523-4F98-AEAA-6A43E7673A3B

P698

Q37118772-60743EDC-918C-4AD3-A6DA-18958A166E89

P921

Q37118772-128185CD-1F76-4A09-8290-66B3FF2F42CF

Q37118772-4052475A-4CB2-48B7-BE5D-C5381F740B06

Q37118772-DBEB6AAA-F424-4271-985B-FA894C7BBC7B

P932

Q37118772-FE3D44E8-B45F-4461-BF01-7C077CF88F64

P356

P1433

P1476

Hyodeoxycholic acid improves H ...... ormation in LDLR-knockout mice

@en

P2093

Boris Ratiner

http://www.w3.org/2001/XMLSchema#string

Diana M Shih

http://www.w3.org/2001/XMLSchema#string

Filiberto Zadini

http://www.w3.org/2001/XMLSchema#string

Giorgio Zadini

http://www.w3.org/2001/XMLSchema#string

Judy Wu

http://www.w3.org/2001/XMLSchema#string

Melenie Rosales

http://www.w3.org/2001/XMLSchema#string

Xuping Wang

http://www.w3.org/2001/XMLSchema#string

Yonghong Meng

http://www.w3.org/2001/XMLSchema#string

Zory Shaposhnik

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamin D receptor as an intestinal bile acid sensor

Formation of hyodeoxycholic acid from muricholic acid and hyocholic acid by an unidentified gram-positive rod termed HDCA-1 isolated from rat intestinal microflora

Atherosclerosis

A simple method for the isolation and purification of total lipides from animal tissues

Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

P304

3805-3817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.12-223008

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Aldons Jake Lusis

P577

2013-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23752203

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

hyodeoxycholic acid

P932

3752541

http://www.w3.org/2001/XMLSchema#string